Editor Name: Dr. Inaki Comino Mendez
Educational Qualification: Ph.D.
Designation: Postdoctoral Training Fellow at The Institute of Cancer Research, UK
Department: Molecular Oncology
Autonomous University of Madrid
Research Interest: Biochemistry, Molecular Biology, Biomedicine and Biotechnology
Biography: Dr. Iñaki Comino-Méndez is a Postdoctoral Training Fellow in London at The Institute of Cancer Research. He is specialized in the use of next generation sequencing (NGS) techniques applied to decipher both genetic susceptibilities to cancer as well as to circulating free DNA (cfDNA) to identified tumor molecular recurrence before clinically detectable. Dr. Iñaki Comino-Méndez obtained his BS degrees in Biology and Biochemist in the University of Navarra (Pamplona, Spain) in 2009. After completing his master’s degree in biotechnology at the Autonomous University of Madrid (Madrid, Spain), he moved in 2015 to the Spanish National Cancer Research Centre (CNIO) where he obtained his PhD degree in the field of the identification of new susceptibility genes involved in the development of pheochromocytoma and paraganglioma. He joined the Molecular Oncology Group at The Institute of Cancer Research as Postdoctoral Training Fellow in 2015. Specialized in breast cancer, his major aim is to investigate the utilization of NGS techniques, using cfDNA, to diagnose, monitor disease burden and determine prognosis, detect recurrence before clinical relapse, evaluate therapy response, track clone evolution and prediction of relapse as well as to decipher tumor heterogeneity.